RTGN (RetinalGenix Technologies) Treasury Stock: $0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RTGN RetinalGenix Technologies Inc RTGN
30 GF Score
Price $4.00
! 1 Warning Sign
View Full Analysis

What is RetinalGenix Technologies Treasury Stock?

RetinalGenix Technologies RTGN +25.00% 30 Treasury Stock is $0.00 Mil as of Mar. 2026. GuruFocus rates RTGN with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

Treasury stock is the portion of shares that a company keeps in their own treasury. RetinalGenix Technologies's treasury stock for the quarter that ended in Mar. 2026 was $0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

RetinalGenix Technologies Treasury Stock Historical Data

* Premium members only.

The historical data trend for RetinalGenix Technologies's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RetinalGenix Technologies Treasury Stock Chart

RetinalGenix Technologies Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Treasury Stock
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

RetinalGenix Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
RTGN
30GF Score
RetinalGenix Technologies Inc RTGN
Treasury Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RetinalGenix Technologies Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of $0.00 Mil mean?
RetinalGenix Technologies (RTGN) has a Treasury Stock of $0.00 Mil as of Mar. 2026. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for RetinalGenix Technologies and its competitors.
Is RetinalGenix Technologies' Treasury Stock too high?
RetinalGenix Technologies' current Treasury Stock is $0.00 Mil. Overall, RetinalGenix Technologies has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does RetinalGenix Technologies' Treasury Stock compare to SNWV and NNOX?
RetinalGenix Technologies' Treasury Stock of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Medical Devices & Instruments company?
A good Treasury Stock depends on the Medical Devices & Instruments industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for RetinalGenix Technologies and its competitors. RetinalGenix Technologies's current Treasury Stock is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RetinalGenix Technologies stock overvalued right now?
RetinalGenix Technologies (RTGN) has a current Treasury Stock of $0.00 Mil. The current Treasury Stock is $0.00 Mil. RetinalGenix Technologies' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For RetinalGenix Technologies (RTGN), the current Treasury Stock is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RetinalGenix Technologies Business Description

Address 409 Apollo Beach Boulevard, Suite 6, Apollo Beach, FL, USA, 33572
RetinalGenix Technologies Inc is an ophthalmic research and development company focused on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders, Its mission is to prevent vision loss and blindness due to diabetic retinopathy and maculopathy through early detection from the use of two devices: Retinal Imaging Screening Device a portable, retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCamTM, being designed as a high-resolution home monitoring retinal imaging device and physician alert system offering real-time communication with physicians available.
30GF Score

Get the complete analysis for RTGN

Treasury Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.00
Price